Lily Hechtman Selected Research

Lily Hechtman Research Topics

70	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2022 - 05/2002
7	Substance-Related Disorders (Drug Abuse) 01/2018 - 09/2003
5	Learning Disabilities (Learning Disability) 07/2004 - 07/2004
3	Oppositional Defiant Disorder 03/2011 - 01/2003
2	Confusion (Bewilderment) 07/2008 - 07/2008
1	Anxiety Disorders (Anxiety Disorder) 01/2022
1	Bulimia Nervosa 04/2010
1	Nausea 02/2007
1	Headache (Headaches) 02/2007
1	Anorexia 02/2007
1	Sleep Initiation and Maintenance Disorders (Insomnia) 02/2007

36	Pemetrexed (MTA)FDA Link 01/2022 - 05/2002
12	Methylphenidate (Ritalin)FDA LinkGeneric 09/2012 - 01/2003
3	Dextroamphetamine (Dexedrine)FDA LinkGeneric 05/2014 - 04/2006
2	CatecholaminesIBA 01/2020 - 01/2017
2	Dopamine (Intropin)FDA LinkGeneric 01/2017 - 05/2014
2	Amphetamine (Amfetamine)FDA LinkGeneric 05/2014 - 09/2012
2	Paroxetine (Paxil)FDA LinkGeneric 03/2011 - 04/2006
1	Flavin-Adenine Dinucleotide (FAD)IBA 01/2022
1	Illicit Drugs (Recreational Drugs)IBA 01/2018
1	trans-sodium crocetinate (crocetin)IBA 12/2015
1	RacloprideIBA 05/2014
1	Lactose FDA LinkGeneric 05/2014
1	BuffersIBA 08/2012
1	Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric 10/2007
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 05/2006
1	Aligeron (AS 2)IBA 01/2003

52	Combined Modality Therapy 01/2022 - 05/2002
6	Therapeutics 01/2020 - 07/2004
2	Aftercare (After-Treatment) 08/2012 - 05/2009
1	Drug Therapy (Chemotherapy) 01/2020
1	Ambulatory Care (Outpatient Care) 02/2007